Spotlight on management of hypertrophic cardiomyopathy

Spotlight on management of hypertrophic cardiomyopathy

Автор: El-Assaly Mohammed

Журнал: Cardiometry @cardiometry

Рубрика: Review

Статья в выпуске: 5, 2014 года.

Бесплатный доступ

Hypertrophic cardiomyopathy (HCM) is the commonest inherited cardio-myopathy. Prevalence 1/500 individuals. The disease has variable expressivity and penetrance, which leads to a diverse phenotypical expression. The aim of this review paper is to shed light on management of HCM.

Cardiac magnetic resonance imaging, left ventricular outflow tract obstruction, hypertrophic cardiomyopathy, left ventricular hypertrophy, sudden cardiac death

Короткий адрес: https://sciup.org/148308793

IDR: 148308793

Список литературы Spotlight on management of hypertrophic cardiomyopathy

  • Spirito P, Seidman CE, McKenna WJ, Maron BJ. The management of hyper-trophic cardiomyopathy. N Engl J Med. 1997;336(11):775-85. http://www.ncbi.nlm.nih.gov/pubmed/9052657
  • ESC Working Group on Myocardial Pericardial Diseases (Elliott P et al. EHJ 2007)
  • Cannavale A, Ordovas KG, Higgins CB: Magnetic Resonance Imaging of hy-pertrophic cardiomyopathy. J Thorac Imaging 2013 Jan;28(1):W12-8 DOI: 10.1097/RTI.0b013e3181e85e8b
  • Hansen MW, Merchant N. MRI of hypertrophic cardiomyopathy: part I, MRI appearances. AJR Am J Roentgenol. 2007; 189:1335-1343. http://www.ajronline.org/doi/abs/10.2214/AJR.07.2286
  • Frenneaux MP, Counihan PJ, Caforio ALP, Chikamori T, McKenna WJ. Abnormal blood pressure response during exercise in hypertrophic cardiomyopathy. Circulation 1990;82:1995-2002 DOI: 10.1161/01.CIR.82.6.1995
  • Yoshida N, Ikeda H, Wada T, et al. Exercise-induced abnormal blood pressure response are related to subendocardial ischemia in hypertrophic cardiomyopathy. J Am Coll Cardiol 1998;32:1938-42.
  • Zheng ZJ, Croft JB, Giles WH, et al. Sudden Cardiac Death in the United States, 1989 to 1998. Circulation. 2001;104:2158-63.
  • Matsubara H, Nakatani S, Nagata S, Ishikura F, Katagiri Y, Ohe T, Miyatake K. Salutary effect of disopyramide on left ventricular diastolic function in hyper-trophic obstructive cardiomyopathy. J Am Coll Cardiol. 1995; 26: 768-75.
  • Michael A. Fifer, Gus J. Vlahakes. Management of Symptoms in Hypertrophic Cardiomyopathy Circulation. 2008; 117: 429-439. http://circ.ahajournals.org/content/117/3/429.extract DOI: 10.1161/CIRCULATIONAHA.107.694158
  • Jeffrey B. Geske, Paul Sorajja, Steve R. Ommen, Rick A. Nishimura. Varia-bility of Left Ventricular Outflow Tract Gradient During Cardiac Catheterization in Patients With Hypertrophic Cardiomyopathy. J Am Coll Cardiol Intv. 2011;4(6):704-709. http://interventions.onlinejacc.org/article.aspx?articleid=1112506 DOI: 10.1016/j.jcin.2011.02.014
  • Maron M.S., Olivotto I., Betocchi S, et al. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med. 2003 Jan 23;348(4):295-303. http://www.ncbi.nlm.nih.gov/pubmed/12540642
  • Effect of Septal Ablation on Myocardial Relaxation and Left Atrial Pressure in Hypertrophic Cardiomyopathy.An Invasive Hemodynamic Study. J Am Coll Cardiol Intv. 2008;1(5):552-60. http://interventions.onlinejacc.org/article.aspx?articleid=1110293 DOI: 10.1016/j.jcin.2008.07.004
  • El-Jack SS, Nasif M, Blake JW, Dixon SR, Grines CL, O'Neill WW. Predic-tors of complete heart block after alcohol septal ablation for hypertrophic cardi-omyopathy and the timing of pacemaker implantation. J Interv Cardiol. 2007;20(1):73-6. http://www.ncbi.nlm.nih.gov/pubmed/17300408
  • Gietzen FH, Leuner CJ, Raute-Kreinsen U, et al. Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH). Catheter interven-tional treatment for hypertrophic obstructive cardiomyopathy. Eur Heart J. 1999;20(18):1342-54. http://www.ncbi.nlm.nih.gov/pubmed/10462469
  • Kuhn H, Seggewiss H, Gietzen FH, Boekstegers P, Neuhaus L, Seipel L. Catheter-based therapy for hypertrophic obstructive cardiomyopathy. First in-hospital outcome analysis of the German TASH Registry. Z Kardiol. 2004 Jan;93(1):23-31. http://www.ncbi.nlm.nih.gov/pubmed/14740238
  • Maron BJ. Controversies in Cardiovascular Medicine Surgical Myectomy Remains the Primary Treatment Option for Severely Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy. Circulation. 2007;116:196-206. http://circ.ahajournals.org/content/116/2/196.extract DOI: 10.1161/CIRCULATIONAHA.107.691378
  • Ralph-Edwards A, Woo A, McCrindle BW, et al. Hypertrophic obstructive cardiomyopathy: comparison of outcomes after myectomy or alcohol ablation adjusted by propensity score. J Thorac Cardiovasc Surg. 2005;129(2):351-8. http://www.ncbi.nlm.nih.gov/pubmed/15678046
  • Firoozi S, Elliott PM, Sharma S, et al. Septal myotomy-myectomy and trans-coronary septal alcohol ablation in hypertrophic obstructive cardiomyopathy. A comparison of clinical, haemodynamic and exercise outcomes. Eur Heart J. 2002;23:1617-24. http://eurheartj.oxfordjournals.org/content/23/20/1617.full.pdf DOI: 10.1053/euhj.2002.3285
  • Lampert R, Salberg L, Burg M. Emotional stress triggers symptoms in hyper-trophic cardiomyopathy: a survey of the Hypertrophic Cardiomyopathy Associ-ation.Pacing Clinic Electrophysiol. 2010 Sep;33(9):1047-53. http://www.ncbi.nlm.nih.gov/pubmed/20487360 DOI: 10.1111/j.1540-8159.2010.02770.x
Еще
Статья обзорная
QR-код для установки приложения SciUp Наведите камеру и скачайте бесплатное приложение SciUp